Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update

Research output: Contribution to journal › Editorial › peer-review

48 Downloads (Pure)

Original language	English
Journal	The Pharmacogenomics Journal
Early online date	18 Dec 2019
DOIs	https://doi.org/10.2217/pgs-2019-0154
Publication status	Published - Jan 2020

Keywords

@article{f8c7550908514ba3b953004023069012,

title = "Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update",

keywords = "Methotrexate, DMARD, Rheumatoid arthritis, Treatment response, Pharmacogenetics, Genetics, Precision medicine, Biomarkers",

author = "Stephanie Ling and James Bluett",

year = "2020",

month = jan,

doi = "10.2217/pgs-2019-0154",

language = "English",

journal = "The Pharmacogenomics Journal",

issn = "1470-269X",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update

AU - Ling, Stephanie

AU - Bluett, James

PY - 2020/1

Y1 - 2020/1

KW - Methotrexate

KW - DMARD

KW - Rheumatoid arthritis

KW - Treatment response

KW - Pharmacogenetics

KW - Genetics

KW - Precision medicine

KW - Biomarkers

U2 - 10.2217/pgs-2019-0154

DO - 10.2217/pgs-2019-0154

M3 - Editorial

SN - 1470-269X

JO - The Pharmacogenomics Journal

JF - The Pharmacogenomics Journal

ER -